By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 2nd Annual Gene Therapy Comparability Summit One of the biggest hurdles in obtaining market authorization for gene therapies is the ability to effectively demonstrate comparability when changes are made during development.
The event will focus on enhancing the participant's gene therapy compatibility, ensuring that one can maintain safety, quality, consistency and efficacy.
The event will help the participant avoid costly delays to clinical programs and adapt manufacturing processes, methods and more to satisfy regulatory demands.
Growth and networking opportunities along with a chance to get in touch with investors for the stream are a few important takeaways.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
Touchlight AAV is advancing gene therapy by offering, dbDNA, its synthetic, linear, double stranded DNA as the new industry standard for transfection-based AAV production.
Wyatt Technology is the leading provider of advanced tools for the characterization of macromolecules and nanoparticles in solution, measuring absolute molar mass, size, charge and interactions.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.